Esperion Therapeutics Inc
(NAS:ESPR)
$
2.12
0.12 (6%)
Market Cap: 415.99 Mil
Enterprise Value: 472.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 53/100 Esperion Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021 / 06:00PM GMT
Release Date Price:
$12
(+3.36%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/research disclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. For this session, we have from Esperion, CEO, Sheldon Koenig; CFO, Rick Bartram; and CMO, Dr. Joanne Foody. Welcome.
Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director
Hey, Jeff. Thanks for having us.
Joanne Micale Foody
Esperion Therapeutics, Inc. - Chief Medical Officer
Hi.
Jeff Hung;Sheldon L. Koenig<
Morgan Stanley, Research Division - Equity Analyst
Thank you for joining. So for those who may not be familiar with Esperion, can you provide a brief introduction?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot